Literature DB >> 26070465

Neuro-ophthalmologic exploration in non-functioning pituitary adenoma.

Lucie Abouaf1, Alain Vighetto2, Maud Lebas3.   

Abstract

Non-functioning pituitary adenoma may lead to blindness and causes visual impairment in 58% of cases and, more rarely, ocular motor disorder. Patients are slow to become aware of their visual dysfunction, vision in one eye compensating the deficit in the other. Assessment of visual function, comprising visual acuity and visual field evaluation and fundus examination, should be performed regularly according to the severity of impairment. Optic nerve optical coherence tomography (OCT) can quantify optic atrophy reproducibly, and is of prognostic value for postoperative visual recovery. Diplopia most often involves decompensation of heterophoria, visual field fusion being hampered by the visual field defect; such diplopia without ocular motor deficit is known as "hemifield slide". Diplopia associated with ocular motor palsy is caused by tumoral invasion of the cavernous sinus (IIIrd, IVth or VIth nerve palsy); in large impairment, restricted eye movement is easily observed; milder palsies require neuro-ophthalmologic assessment and/or Lancaster test. Pituitary apoplexy induces ocular motor impairment in 70% of cases, strongly guiding diagnosis. Visual impairment is associated in 75% of cases. The degree of neuro-ophthalmologic (visual and ocular motor) impairment is one of the main criteria guiding treatment of pituitary apoplexy (conservative medical and/or surgical treatment) and follow-up.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Adénome hypophysaire; Adénome hypophysaire non fonctionnel; Altération du champ visuel; Diplopia; Diplopie; Non-functioning pituitary adenoma; Pituitary adenoma; Visual field defect

Mesh:

Year:  2015        PMID: 26070465     DOI: 10.1016/j.ando.2015.04.006

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  8 in total

Review 1.  Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options.

Authors:  P D Delgado-López; J Pi-Barrio; M T Dueñas-Polo; M Pascual-Llorente; M C Gordón-Bolaños
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

2.  Relationship between postoperative volume of macroadenomas and clinical outcome after endoscopic trans-sphenoidal resection.

Authors:  Valeria Onofrj; Carina Vallejo; Paulo Puac; Carlos Zamora; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2018-08-09

Review 3.  Pituitary Adenomas: From Diagnosis to Therapeutics.

Authors:  Samridhi Banskota; David C Adamson
Journal:  Biomedicines       Date:  2021-04-30

Review 4.  The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration.

Authors:  Arif Abdulbaki; Imad Kanaan
Journal:  Surg Neurol Int       Date:  2017-02-06

5.  Comparative Evaluation of Two SD-OCT Macular Parameters (GCC, GCL) and RNFL in Chiasmal Compression.

Authors:  Mélissa Santorini; Thomas Ferreira De Moura; Sara Barraud; Claude Fabien Litré; Catherine Brugniart; Alexandre Denoyer; Zoubir Djerada; Carl Arndt
Journal:  Eye Brain       Date:  2022-03-05

6.  Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience.

Authors:  Max J van Essen; Ivo S Muskens; Nayan Lamba; Stephan F J Belunek; Arthur T J van der Boog; G Johan Amelink; Peter H Gosselaar; Tristan P C van Doormaal; Aline M E Stades; Joost J C Verhoeff; Maria M van Genderen; Christine A E Eenhorst; Marike L D Broekman
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-03

7.  Progressive loss of vision caused by asymptomatic pituitary macroadenoma: role of OCT.

Authors:  Víctor Manuel Asensio-Sánchez; Javier Foncubierta
Journal:  Int Med Case Rep J       Date:  2016-09-16

8.  A Case of Giant Pituitary Adenoma Associated with a Postoperative Mental Disorder That Ultimately Resulted in Bilateral Blindness.

Authors:  Masahiro Tonari; Yuko Nishikawa; Junko Matsuo; Masashi Mimura; Hidehiro Oku; Jun Sugasawa; Naokado Ikeda; Yoshitaka Kurisu; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2020-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.